NASDAQ:JANX | Cash Flow Statement | Janux Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$21.97M
2026-03-31-$24.36M-$12.34M$273,000.00$8.29M$3.55M
2025-12-31-$31.95M-$28.54M$106,000.00$29.54M$2.94M
2025-09-30-$24.31M
2025-06-30-$33.86M
2025-03-31-$23.51M-$17.02M$371,000.00-$340.39M$554,000.00
2024-12-31-$20.22M-$16.73M$42,000.00$33.93M$386.65M
2024-09-30-$28.06M
2024-06-30-$5.96M
2024-03-31-$14.76M-$14.84M$197,000.00-$113.74M$322.17M
2023-12-31-$11.76M-$9.9M$515,000.00$11.12M$831,000.00
2023-09-30-$11.57M
2023-06-30-$17.51M
2023-03-31-$17.46M-$13.91M$285,000.00-$8.74M$1.58M
2022-12-31-$16.07M-$11.91M$2.06M-$1.6M$191,000.00
2022-09-30-$16.7M
2022-06-30-$16.89M
2022-03-31-$13.41M-$11.52M$971,000.00$31.07M$1,000.00
2021-12-31-$13.42M-$10.48M$1.17M$7.33M$164,000.00
2021-09-30-$10.77M
2021-06-30-$6.21M
2021-03-31-$2.28M$5.56M$153,000.00-$153,000.00$57.55M
2020-12-31-$1.66M-$1.63M$0.00$0.00$4.55M
2020-09-30-$1.26M
2020-06-30-$2.46M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$113.63M-$82.24M$1.04M-$300.98M$4.95M
2024-12-31-$68.99M-$43.81M$359,000.00-$258.02M$713.24M
2023-12-31-$58.29M-$50.58M$1.85M-$41.19M$59.55M
2022-12-31-$63.06M-$42.92M$6.45M$58.27M$500,000.00
2021-12-31-$32.67M-$16.98M$1.48M-$340.96M$386.52M
2020-12-31-$6.78M-$4.37M$0.00$0.00$11.52M